当前位置:药药网 / 数据中心 / 儿科标签更改电子表格2021
Adhansia XR
通用名称
methylphenidate hydrochloride
儿科标签批准日期
2019/2/27 0:00:00
特定指示/秒
Attention Deficit Hyperactivity Disorder
标签更改摘要
- Safety and effectiveness have been established in one adequate and well-controlled 6-week study in pediatric patients ages 6 to 12 years, and in one adequate and well-controlled 4-week study in pediatric patients ages 12 to 17 years.
- Safety and effectiveness in pediatric patients under the age of 6 years have not been established.
- The long-term efficacy of methylphenidate in pediatric patients has not been established.
- Information on dosing, adverse reactions, PK parameters, and clinical trials.
- New dosage form